Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2020-02-28
Original market date: See footnote 1
1975-12-31
Lot number: See footnote 2
KK825401
Expiry date: See footnote 2
2021-08-31
Product name:
ATASOL 15
DIN:
00293504
Product Monograph/Veterinary Labelling:
Date:
2019-11-07
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
CHURCH & DWIGHT CANADA CORP
635 Secretariat Court
Mississauga
Ontario
Canada
L5S 0A5
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
3
Schedule(s):
Narcotic (CDSA I)
American Hospital Formulary Service (AHFS): See footnote 3
28:08.92 , 28:08.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
N02AJ06 CODEINE AND PARACETAMOL
Active ingredient group (AIG) number:See footnote5
0302037003
Active ingredient(s) | Strength |
---|---|
ACETAMINOPHEN | 325 MG |
CAFFEINE CITRATE | 30 MG |
CODEINE PHOSPHATE | 15 MG |